White coat notes
Facing passionate objections from doctors, the state has backed off from its plan -- at least for now -- to sell data to researchers, insurers, and companies that could be used to analyze individual physicians' track records. (Full article: 544 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
